Cerity Partners’s Biohaven BHVN Stock Holding History

Cerity Partners’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$954K	Buy	112,825 +65,682	+139%	+$719K	﹤0.01%	1884
2025 Q4	$532K	Buy	+47,143	New	+$584K	﹤0.01%	2068

Other funds holding BHVN

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

RPSM

Royalty Pharma Sub-Manager New York $173M AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cerity Partners's BHVN Position: Q1 2026 in Review

Cerity Partners increased its Biohaven (BHVN) stake by 139% in Q1 2026, buying an estimated $719K and bringing the position to 112,825 shares worth $954K. The position accounts for ﹤0.01% of the portfolio, ranked #1884.

Cerity Partners first reported a position in BHVN in Q4 2025 and has held it in 2 quarters since. 275 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

Cerity Partners held 112,825 shares of Biohaven worth $954K as of Q1 2026.
Cerity Partners bought 65,682 Biohaven shares in Q1 2026, an estimated $719K.
Biohaven made up ﹤0.01% of Cerity Partners's portfolio in Q1 2026, its #1884 holding.
Cerity Partners first reported a position in Biohaven in Q4 2025 and has held it in 2 quarters since.
275 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.